LANTHIONINE-CONTAINING ANTIMICROBIAL COMPOUND

A lanthionine-containing antimicrobial peptide obtainable from Staphylococcus hyicus strain 664 and pharmaceutically acceptable acid addition salts thereof as well as pharmaceutical compositions comprising said peptide or its acid addition salts and DNA molecules encoding said peptide are described....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PEEL, JOHN EDMONDSON, RASCHDORF, FRITZ, SCHNEIDER, JOSEF, SURI, BRUNO
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A lanthionine-containing antimicrobial peptide obtainable from Staphylococcus hyicus strain 664 and pharmaceutically acceptable acid addition salts thereof as well as pharmaceutical compositions comprising said peptide or its acid addition salts and DNA molecules encoding said peptide are described. The peptide is purified from the culture medium of Staphylococcus hyicus strain 664 and can be used in a method of treating or preventing mastitis in a mammal comprising administering to said mammal a pharmaceutically effective amount of the peptide or a pharmaceutically acceptable acid addition salt thereof to effectively treat mastitis or effectively to suppress the rate, severity, and duration of subsequent bacterial infection.